✦ LIBER ✦

A randomized study of adjuvant immunotherapy with levamisole and corynebacterium parvum in operable non-small cell lung cancer

✍ Scribed by Richard M. Fox; Robert L. Woods; Martin H.N. Tattersall; Antony Basten

Publisher: Elsevier Science
Year: 1980
Tongue: English
Weight: 301 KB
Volume: 6
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(80)90115-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized phase III trial of adjuvant

A randomized phase III trial of adjuvant treatment for resected non-small cell lung cancer in Japan

✍ Yukito Ichinose 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 294 KB

Post-operative thoracic irradiation with

Post-operative thoracic irradiation with or without levamisole in non-small cell lung cancer: results of a radiation therapy oncology group study

✍ Arnold Herskovic; Madeline Bauer; H. Gunter Seydel; Raymond Yesner; R.L. Scotte 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 638 KB

Immunotherapy with intralesional and sys

Immunotherapy with intralesional and systemic interleukin-2 of patients with non-small-cell lung cancer

✍ Marco Scudeletti; Gilberto Filaci; Maria A. Imro; Giovanni Motta; Marina Di Gaet 📂 Article 📅 1993 🏛 Springer-Verlag 🌐 English ⚖ 612 KB

Role of routine postoperative radiothera

Role of routine postoperative radiotherapy and nonspecific immunotherapy with BCG in combination with adjuvant chemotherapy in operable breast cancer a prospective randomized trial

✍ A.U. Buzdar; G.N. Hortobagyi; G.R. Blumenschein; E.M. Hersh 📂 Article 📅 1981 🏛 Elsevier Science 🌐 English ⚖ 107 KB

A randomized trial of three cisplatin-co

A randomized trial of three cisplatin-containing regimens in advanced non-small-cell lung cancer (NSCLC): a study of the Umbrian Lung Cancer Group

✍ Lucio Crino; Maurizio Tonato; Samir Darwish; Maria L. Meacci; Enrichetta Corgna; 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 485 KB

Survival in operable non-small-cell lung

Survival in operable non-small-cell lung cancer: Role of p53 mutations, tobacco smoking and asbestos exposure

✍ Thanos Sioris; Kirsti Husgafvel-Pursiainen; Antti Karjalainen; Sisko Anttila; An 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 68 KB 👁 2 views

Validated markers are needed to identify operable lung cancer patients with poor prognosis. About one-half of nonsmall-cell lung cancers (NSCLCs) carry a mutation in the p53 tumor-suppressor gene. We examined 101 NSCLC patients for surgical stage, completeness of resection, tobacco smoking, asbestos